Number of respondents by (selected*) first cancer site and date of diagnosis: Fee-For-Service

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 16,464 3,746 22.8 2,795 17.0 3,078 18.7 4,103 24.9 2,742 16.7
Breast 15,440 3,429 22.2 2,104 13.6 2,457 15.9 3,349 21.7 4,101 26.6
Colorectal 8,195 2,543 31.0 1,350 16.5 1,237 15.1 1,532 18.7 1,533 18.7
Lung and Bronchial 6,420 4,142 64.5 992 15.5 550 8.6 474 7.4 262 4.1
Ovary 919 307 33.4 138 15.0 108 11.8 134 14.6 232 25.2
Uterine Corpus 2,753 540 19.6 349 12.7 346 12.6 526 19.1 992 36.0
Uterine Cervix 1,020 56 5.5 32 3.1 36 3.5 85 8.3 811 79.5
Bladder 3,992 1,363 34.1 680 17.0 628 15.7 706 17.7 615 15.4
Melanoma 5,134 1,371 26.7 848 16.5 854 16.6 1,009 19.7 1,052 20.5
Head and Neck 4,530 1,600 35.3 713 15.7 717 15.8 717 15.8 783 17.3
Kidney and Renal Pelvis 1,964 745 37.9 330 16.8 290 14.8 347 17.7 252 12.8
Non-Hodgkin Lymphomas 2,773 1,030 37.1 470 16.9 444 16.0 468 16.9 361 13.0
Leukemia 1,596 714 44.7 253 15.9 214 13.4 253 15.9 162 10.2
Stomach 759 415 54.7 111 14.6 74 9.7 95 12.5 64 8.4
Esophagus 420 261 62.1 65 15.5 36 8.6 36 8.6 22 5.2
Pancreas 1,007 828 82.2 107 10.6 34 3.4 23 2.3 15 1.5

*Sites reflect most prevalent cancer sites in SEER-CAHPS